0 items USD 0.00Search
Your search for "delveinsight acromegaly gigantism epidemiology forecast 2023" gave back 1532780 results.
Somatuline is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome The...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Lanreotide (INN) is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Somatuline is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome The...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Lanreotide (INN) is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Somatostatin Receptor Type 2 - Pipeline Review, H2 2019 Summary Somatostatin Receptor Type 2 (SRIF1 or SSTR2) pipeline Target constitutes close to 13...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
A decade has gone, since the first human genome has been sequenced and sequencing technology has come a long way from the time of introduction as...
Catalog:
IQ4I
November 2014
Price: USD 4,500.00
Somatostatin Receptor Type 4 (SSTR4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022...
Catalog:
Global Markets Direct
May 2022
Price: USD 3,500.00
Somatostatin Receptor Type 4 (SSTR4) - Drugs In Development, 2021 Summary Somatostatin Receptor Type 4 (SSTR4) pipeline Target constitutes close to 5...
Catalog:
Global Markets Direct
June 2021
Price: USD 3,500.00
Summary Publisher estimates that the Hematological Cancers market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a...
Catalog:
HYR
May 2021
Price: USD 2,000.00
Somatuline is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome The...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Lanreotide (INN) is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Summary HeyReport estimates that the Hematological Cancers market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a...
Catalog:
HYR
January 2021
Price: USD 2,000.00
“Diabetic Foot Ulcer (DFU) Pipeline Analysis” gives comprehensive insights on the various drugs being developed for the treatment of DFU. The report...
Catalog:
IQ4I
December 2018
Price: USD 3,600.00
Somatuline is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome The...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Lanreotide (INN) is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
